Peptide-based cationic molecules for the production of positive charged liposomes and micelles

Journal of Microencapsulation

Volumn 25, Issue 2, 2008, Pages 71-81

  Cortesi, R ^a   Marastoni, M ^a   Tomatis, R ^a   Menegatti, E ^a   Esposito, E ^a   Nastruzzi, C ^b  

^a UNIVERSITY OF FERRARA   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Cationic drug delivery systems; Liposomes; Micelles; Peptide

Indexed keywords

CATION; DEFIBROTIDE; LIPOSOME; PEPTIDE DERIVATIVE;

ARTICLE; CELL STRAIN K 562; CHEMICAL BINDING; CONTROLLED STUDY; CYTOTOXICITY; DNA BINDING; ELECTRIC POTENTIAL; HUMAN; HUMAN CELL; MICELLE; MOLECULAR INTERACTION; MOLECULAR SIZE; NONVIRAL GENE DELIVERY SYSTEM; PHYSICAL CHEMISTRY; POROSITY; REFERENCE VALUE; SYNTHESIS; ZETA POTENTIAL;

DNA; DRUG DELIVERY SYSTEMS; GENE THERAPY; GENE TRANSFER TECHNIQUES; HUMANS; K562 CELLS; LIPOSOMES; MICELLES; PEPTIDES; POLYDEOXYRIBONUCLEOTIDES;

EID: 39049099843     PISSN: 02652048     EISSN: 14645246     Source Type: Journal    
DOI: 10.1080/02652040701711403     Document Type: Article

References (24)

1. Brandwijk, RJ, Griffioen, AW and Thijssen, VL (2007) Targeted gene-delivery strategies for angiostatic cancer treatment. Trends in Molecular Medicine, 13, pp. 200-209.
2. Cimminiello, C. (1996) Clinical trials with defibrotide in vascular disorders. Seminars in Thrombosis and Hemostasis, 22, pp. 29-34.
3. Cortesi, R., Esposito, E., Gambari, R., Menegatti, E. and Nastruzzi, C. (1994) Liposome-associated synthetic oligonucleotides: Production and in vitro release kinetics. Pharmaceutical Pharmacological Letters, 3, pp. 213-216.
4. Cortesi, R., Esposito, E., Menegatti, E., Gambari, R. and Nastruzzi, C. (1996) Effect of cationic liposome composition on their in vitro citotoxicity and protective effect on carried DNA. International Journal of Pharmaceutics, 139, pp. 69-78.
5. Cryan, SA and O'Driscoll, CM (2003) Mechanistic studies on non-viral gene delivery to the intestine using in vitro differentiated cell culture models and an in vivo rat intestinal loop. Pharmaceutical Research, 20, pp. 569-575.
6. Gieselmann, V., Matzner, U., Klein, D., Mansson, JE, D'Hooge, R., Dedeyn, PD, Rauch, R Lullmann, Hartmann, D. and Harzer, K. (2003) Gene therapy: Prospects for glycolipid storage diseases. Philosophical Transactions of the Royal Society of London,. B: Biological Science, 358, pp. 921-925.
7. Hart, SL (2005) Lipid carriers for gene therapy. Current Drug Delivery, 2, pp. 423-428.
8. Kabanov, AV, Batrakova, EV and Alakhov, VY (2002) Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. Journal of Controlled Release, 82, pp. 189-212.
9. Li, S-D and Huang, L. (2006) Surface-modified LPD nanoparticles for tumor targeting. Annals of the New York Academy of Science, 1082, pp. 1-8.
10. Lozzio, CB and Lozzio, BB (1975) Human chronic myelogeneous leukemia cell line with positive Philadelphia chromosome. Blood, 45, pp. 321-334.
11. Lv, H., Zhang, S., Wang, B., Cui, S. and Yan, J. (2006) Toxicity of cationic lipids and cationic polymers in gene delivery. Journal of Controlled Release, 114, pp. 100-109.
12. Maitra, A. (2005) Calcium phosphate nanoparticles: Second-generation nonviral vectors in gene therapy. Expert Review in Molecular Diagnosis, 5, pp. 893-905.
13. Martin, ME and Rice, KG (2007) Peptide-guided gene delivery. AAPS Journal, 9, pp. E18-E29.
14. Pietersz, GA, Tang, CK and Apostolopoulos, V. (2006) Structure and design of polycationic carriers for gene delivery. Mini Review in Medicinal Chemistry, 6, pp. 1285-1298.
15. Kumar, M Ravi, Hellermann, G., Lockey, RF and Mohapatra, SS (2004) Nanoparticle-mediated gene delivery: State of the art. Expert Opinion in Biology Therapeutics, 4, pp. 1213-1224.
16. Rivest, V., Phivilay, A., Julien, C., Belanger, S., Tremblay, C., Emond, V. and Calon, F. (2007) Novel liposomal formulation for targeted gene delivery. Pharmaceutical Research, 24, pp. 981-990.
17. Ruponen, M., Yla-Herttuala, S. and Urtti, A. (1999) Interactions of polymeric and liposomal gene delivery systems with extracellular glycosaminoglycans: Physicochemical and transfection studies. Biochimica et Biophysica Acta, 1415, pp. 331-341.
18. Siddiqui, F., Barton, KN, Stricker, HJ, Steyn, PF, Larue, SM, Karvelis, KC, Sparks, RB, Kim, JH, Brown, SL and Freytag, SO (2007) Design considerations for incorporating sodium iodide symporter reporter gene imaging into prostate cancer gene therapy trials. Human Gene Therapy, 18, pp. 312-322.
19. Szoka, F. and Papahadjopoulos, D. (1978) Procedure for preparation of liposomes with large internal aqueous space and high capture by reverse phase evaporation. Proceedings of the National Academy of Sciences (USA), 75, pp. 4194-4198.
20. Tomlinson, E. and Rolland, AP (1995) Controllable gene therapy. Pharmaceutics of non-viral gene delivery systems. Journal of Controlled Release, 39, pp. 357-372.
21. Torchilin, V. (2006) Recent approaches to intracellular delivery of drugs and DNA and organelle targeting. Annual Review of Biomedical Engineering, 8, pp. 343-375.
22. Wasungu, L. and Hoekstra, D. (2006) Cationic lipids, lipoplexes and intracellular delivery of genes. Journal of Controlled Release, 116, pp. 255-264.
23. Zhang, H., Wang, S., Cui, B. and Yan, S. (2006) Toxicity of cationic lipids and cationic polymers in gene delivery. Journal of Controlled Release, 114, pp. 100-109.
24. Zhu, D., Lennon, SP, Peters, MH, Finney, WC and Singh, M. (2006) Brownian diffusion and surface kinetics of liposome and viral particle uptake by human lung cancer cells in-vitro. Annals of Biomedical Engineering, 34, pp. 1573-1586.